The Enterprise Value as of November 2024 (TTM) for Ono Pharmaceutical Co., Ltd. (OPHLY) is 934.68B

According to Ono Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 934.68B. This represents a change of -0.48% compared to the average of 939.19B of the last 4 quarters.

Ono Pharmaceutical Co., Ltd. (OPHLY) Historical Enterprise Value (quarterly & annually)

How has OPHLY Enterprise Value performed in the past?

The mean historical Enterprise Value of Ono Pharmaceutical Co., Ltd. over the last ten years is 1.38T. The current 934.68B Enterprise Value has changed 6.65% with respect to the historical average. Over the past ten years (40 quarters), OPHLY's Enterprise Value was at its highest in in the March 2016 quarter at 2.47T. The Enterprise Value was at its lowest in in the June 2024 quarter at 359.41B.

Ono Pharmaceutical Co., Ltd. (OPHLY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ono Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ono Pharmaceutical Co., Ltd. (OPHLY) Average Enterprise Value

How has OPHLY Enterprise Value performed in the past?

The current Enterprise Value of Ono Pharmaceutical Co., Ltd. (OPHLY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ono Pharmaceutical Co., Ltd. (OPHLY) Enterprise Value vs. Peers

How is OPHLY’s Enterprise Value compared to its peers?

Ono Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Santen Pharmaceutical Co., Ltd. (554.61B), greater than GSK plc (70.83B), greater than Grifols, S.A. (14.96B), greater than Pfizer Inc. (225.71B), greater than Sanofi (138.99B), greater than Organon & Co. (4.36B), greater than Horizon Therapeutics Public Limited Company (92.83M), greater than GSK plc (55.00B), greater than AstraZeneca PLC (248.09B), greater than Roche Holding AG (251.86B), greater than Novartis AG (232.94B), greater than Merck & Co., Inc. (284.66B), greater than Bristol-Myers Squibb Company (154.32B), greater than Gilead Sciences, Inc. (132.43B), greater than Amgen Inc. (221.74B), greater than Johnson & Johnson (396.75B), greater than AbbVie Inc. (411.60B),

Build a custom stock screener for Ono Pharmaceutical Co., Ltd. (OPHLY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ono Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ono Pharmaceutical Co., Ltd. (OPHLY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ono Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.